The DOI matches its Crossref record.
Structural and functional properties of ras proteins
Abstract
The ras proteins belong to a family of related polypeptides that are present in all eukaryotic organisms from yeast to human. Their extraordinary evolutionary conservation suggests that they have essential cellular functions, although their exact role remains unknown. Mutations in specific amino acids and overexpression of normal proteins have been linked to altered proliferation and/or differentiation and, particularly, to neoplastic processes. Mature ras proteins are located on the inner side of the plasma membrane, and their biochemical properties include binding and exchange of guanine nucleotides and GTPase activity. The favored hypothesis for ras function is that these proteins exist in an equilibrium between an inactive conformation (p21 · GDP) and an active conformation (p21 · GTP) in which they are able to interact with their as! yet unknown cellular target or targets. Similarities in cellular location, structure, and biochemistry with other known regulatory (G) proteins suggest that they play a role in transduction of signals from the cell surface. The elucidation of the crystal structure of normal and transforming ras proteins and the identification of cellular proteins that interact directly with them (GAP, CDC25) or suppress some of their biological effects (Krev‐1) have opened new avenues in the search for their elusive cellular targets and in the elucidation of the functional role of ras gene products.— S antos , E.; N ebreda , A. R. Structural and functional properties of ras proteins. FASEB J. 3: 2151‐2163; 1989.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Takai, Y., Sasaki, T., & Matozaki, T. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.153 · Cited by 2,475
KRAS Mutation: From Undruggable to Druggable in Cancer
Huang, L., Guo, Z., Wang, F., & Fu, L. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00780-4 · Cited by 1,127
Molecular cloning and expression of an IL-6 signal transducer, gp130
Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., & Kishimoto, T. (1990) · Cell · doi:10.1016/0092-8674(90)90411-7 · Cited by 1,039
Branford, S., Rudzki, Z., Walsh, S., Parkinson, I., Grigg, A., Szer, J., Taylor, K., Herrmann, R., Seymour, J. F., Arthur, C., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2896 · Cited by 765
Takai, Y., Kaibuchi, K., Kikuchi, A., & Kawata, M. (1992) · International Review of Cytology · doi:10.1016/s0074-7696(08)61861-6 · Cited by 516
Qiu, M.-S., & Green, S. H. (1992) · Neuron · doi:10.1016/0896-6273(92)90033-a · Cited by 472
Murakami, M., Narazaki, M., Hibi, M., Yawata, H., Yasukawa, K., Hamaguchi, M., Taga, T., & Kishimoto, T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11349 · Cited by 408
Binding of GAP to Activated PDGF Receptors
Kazlauskas, A., Ellis, C., Pawson, T., & Cooper, J. A. (1990) · Science · doi:10.1126/science.2157284 · Cited by 369
Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line.
Drivas, G. T., Shih, A., Coutavas, E., Rush, M. G., & D'Eustachio, P. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.4.1793 · Cited by 310
Regulators and Effectors of ras Proteins
Bollag, G., & McCormick, F. (1991) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.07.110191.003125 · Cited by 300
Esteban, L. M., Vicario-Abejón, C., Fernández-Salguero, P., Fernández-Medarde, A., Swaminathan, N., Yienger, K., Lopez, E., Malumbres, M., McKay, R., Ward, J. M., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1444-1452.2001 · Cited by 298
Self-citationGibbs, J. B., Marshall, M. S., Scolnick, E. M., Dixon, R. A., & Vogel, U. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30523-9 · Cited by 296
Targeting KRAS mutant cancers: from druggable therapy to drug resistance
Zhu, C., Guan, X., Zhang, X., Luan, X., Song, Z., Cheng, X., Zhang, W., & Qin, J.-J. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01629-2 · Cited by 231
KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne?
Nagasaka, M., Li, Y., Sukari, A., Ou, S.-H. I., Al-Hallak, M. N., & Azmi, A. S. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.101974 · Cited by 185
Mechanisms of Resistance to KRASG12C-Targeted Therapy
Akhave, N. S., Biter, A. B., & Hong, D. S. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1616 · Cited by 156
Carboxyl-terminal isoprenylation of ras-related GTP-binding proteins encoded by rac1, rac2, and ralA
Kinsella, B. T., Erdman, R. A., & Maltese, W. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92889-9 · Cited by 131
Abo, A., & Pick, E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54322-2 · Cited by 79
The Next Generation of KRAS Targeting: Reasons for Excitement and Concern
Akhave, N. S., Biter, A. B., & Hong, D. S. (2022) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0356 · Cited by 17
Metadata
- Authors
- Santos, E., & Nebreda, A. R.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1989-08
- Volume
- 3
- Issue
- 10
- Pages
- 2151-2163
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1549883618
- Cited by
- 219
- References
- 0
- FWCI
- 12.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.